Sarah Khorsand, MD
Critical Care Medicine · Dallas, TXNPI 1497017776
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,074 of the $2,635 with a category attached, or 78.7%. 9 manufacturers reported payments, led by Abiomed at 51.4% of the total. Reporting peaked in 2024 at $847 and has fallen 62.2% since, to $320 in 2025.
Across 24 payments — averaging $109.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$1K
- Pacira Pharmaceuticals Incorporated$465
- Merck$247
- CSL Behring$125
- Grifols USA, LLC$117
- Eagle Pharmaceuticals, Inc.$115
- plus $211 from 3 others
What the payments were for
- Travel & lodging$56121%
- Food & beverage$2,07479%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 11 | $1,356 |
| Pacira Pharmaceuticals Incorporated | 4 | $465 |
| Merck | 2 | $247 |
| CSL Behring | 1 | $125 |
| Grifols USA, LLC | 1 | $117 |
| Eagle Pharmaceuticals, Inc. | 1 | $115 |
| Covidien LP | 1 | $112 |
| Baxter Healthcare | 1 | $51 |
| AbbVie | 2 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,635 in reported general payments places this provider in the 80th percentile of 507 critical care medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Dallas
- Anthony OrtegonDallas$106K
- Gary WeinsteinDallas$103K
- Thomas ArdilesDallas$47K
- Rebecca DoebeleDallas$12K
- Humayun AnjumDallas$11K
- Sridhar BadireddiDallas$11K
- David PhamDallas$10K
- Jake RiceDallas$9K
- Bryan KellyDallas$9K
- Munir HazbunDallas$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.